Mechanisms of Survival Prolongation of Murine Cardiac Allografts Using the Treatment of CTLA4-Ig and MR1

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1618-1624

  Zhu, P ^a   Chen, Y F ^a   Chen, X P ^a   Li, D ^a   Cheng, Q ^a   Huang, Z Y ^a   Zhang, W G ^a   Xiao, Z Y ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PERFORIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TH1 CELL; TH2 CELL;

ABDOMEN; ANIMALS; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MICE; RECOMBINANT PROTEINS; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 45449105366     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.148     Document Type: Article

References (28)

1. Sayegh M.H., and Carpenter C.B. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 351 (2004) 2761
2. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4 (2004) 378
3. + T cells: perforin and FasL play alternate but obligatory roles. Am J Transplant 7 (2007) 1927
4. Magee C., and Pascual M. The growing problem of chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 994
5. Rothstein D.M., and Sayegh M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196 (2003) 85
6. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 (2002) 116
7. Carreno B.M., and Collins M. The B7 family of ligands and its receptors: new pathways forcostimulation and inhibition of immune responses. Annu Rev Immunol 20 (2002) 29
8. Coyle A.J., and Gutierrez-Ramos J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2 (2001) 203
9. Quezada S.A., Jarvinen L.Z., Lind E.F., et al. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22 (2004) 307
10. Morel Y., Truneh A., Sweet R.W., et al. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 167 (2001) 2479
11. Mempel T.R., Henrickson S.E., and Andrian U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427 (2004) 154
12. Lakkis F.G., Arakelov A., Konieczny B.T., et al. Immunologic "ignorance" of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 6 (2000) 686
13. Sayegh M.H., and Turka L.A. The role of T cell costimulatory activation pathways in transplant rejection. N Engl J Med 338 (1998) 1813
14. Wekerle T., Kurtz J., Bigenzahn S., et al. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14 (2002) 592
15. Armstrong A.T., Strauch A.F., Starling R.C., et al. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 63 (1997) 941
16. Gudmundsdottir H., and Turka L.A. T cell costimulatory blockade: new therapies for transplant rejection. J Am Soc Nephrol 10 (1999) 1356
17. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol 169 (2002) 4667
18. Welsh R.M., Markees T.G., Woda B.A., et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol 74 (2000) 2210
19. Valujskikh A., Pantenburg B., and Heeger P.S. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2 (2002) 501
20. Pantenburg B., Heinzel F., Das L., et al. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 169 (2002) 3686
21. Rathmell J.C., and Thompson C.B. The central effectors of cell death in the immune system. Annu Rev Immunol 17 (1999) 781
22. Thomas F., Wu J.J., and Thomas J.M. Apoptosis and organ transplantation. Curr Opin Organ Transplant 5 (2000) 35
23. Lieberman J. Cell death and immunity. Nat Rev Immunol 3 (2003) 361
24. Russell J.H., and Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20 (2002) 323
25. Barry M., and Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2 (2002) 401
26. Rivero M., Crespo J., Mayorga M., et al. Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol 97 (2002) 1501
27. de Groot-Kruseman H.A., Baan C.C., Zondervan P.E., et al. Apoptotic death of infiltrating cells in human cardiac allografts is regulated by IL-2, FASL, and FLIP. Transplant Proc 36 (2004) 3143
28. Pérez E.C., Shulzhenko N., Morgun A., et al. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts. Hum Immunol 67 (2006) 22